...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: THIS IS NEW ,,, What if
5
Jan 15, 2016 10:55AM
Thanks Stock. I think Fouremm's Newco Ownership thread is worth a re-read too. Let's hope we're right...there seems to be a lot of signals that we might be! Woo-hoo!! PVLee
3
Jan 18, 2016 04:00PM
Share
New Message
Please login to post a reply